Survival after neoadjuvant therapy with trastuzumab-lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trials.

ESMO Open · 2022 · PMC8917305 · PMID 35276440

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

of borderline significanceno p-value reported

Although to a lesser extent, pCR was significantly associated with RFS also in the hormone receptor-positive subgroup (HR 0.60, 95% CI 0.37-0.97, Figure 3 C), with a relationship of borderline significance in terms of OS (HR 0.52, 95% CI 0.23-1.15, Figure 4 C).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.